Stockreport

Takeda Pharmaceutical's Potential Plaque Psoriasis Therapy Meets Endpoints in Phase 3 Studies [Yahoo! Finance]

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK) 
PDF Takeda Pharmaceutical (TAK) said Thursday its drug zasocitinib for the treatment of adults with mode [Read more]